SK channel function regulates the dopamine phenotype of neurons in the substantia nigra pars compacta

Experimental Neurology

Volumn 213, Issue 2, 2008, Pages 419-430

  Aumann, T D ^a   Gantois, I ^a   Egan, K ^a   Vais, A ^a   Tomas, D ^a   Drago, J ^a   Horne, M K ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

6 hydroxy dopamine; Dopamine; Mouse; Parkinson's disease; SK; Tyrosine hydroxylase

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; DOPAMINE; DOPAMINE 2 RECEPTOR; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ACTION POTENTIAL; AFTERHYPERPOLARIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ELECTROPHYSIOLOGY; FACILITATION; MOUSE; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUBSTANTIA NIGRA;

ANIMALS; DOPAMINE; MALE; MICE; MICE, INBRED C57BL; NEURONS; PHENOTYPE; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 51349136554     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2008.07.005     Document Type: Article

References (51)

1. AprAtherton J.F., and Bevan M.D. Ionic mechanisms underlying autonomous action potential generation in the somata and dendrites of GABAergic substantia nigra pars reticulata neurons in vitro. J. Neurosci. 25 36 (2005) 8272-8281
2. Ben-Shachar D., Zuk R., et al. Dopamine neurotoxicity: inhibition of mitochondrial respiration. J. Neurochem. 64 2 (1995) 718-723
3. Bjorklund A., Rosenblad C., et al. Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease. Neurobiol. Dis. 4 3-4 (1997) 186-200
4. Bowenkamp K.E., David D., et al. 6-hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor. Exp. Brain Res. 111 1 (1996) 1-7
5. Brosenitsch T.A., and Katz D.M. Physiological patterns of electrical stimulation can induce neuronal gene expression by activating N-type calcium channels. J. Neurosci. 21 8 (2001) 2571-2579
6. Durante P., Cardenas C.G., et al. Low-threshold L-type calcium channels in rat dopamine neurons. J. Neurophysiol. 91 3 (2004) 1450-1454
7. Finkelstein D.I., Stanic D., et al. Stereological procedures for determination of neuronal arbour size. In: Gerfen C., and Wray S. (Eds). Current Protocols in Neuroscience (2004), Wiley, New York April, 1-16
8. Frielingsdorf H., Schwarz K., et al. No evidence for new dopaminergic neurons in the adult mammalian substantia nigra. Proc. Natl. Acad. Sci. U. S. A. 101 27 (2004) 10177-10182
9. Fureman B.E., Campbell D.B., et al. Regulation of tyrosine hydroxylase expression in tottering mouse Purkinje cells. Neurotox. Res. 5 7 (2003) 521-528
10. Gale S.D., and Perkel D.J. Physiological properties of zebra finch ventral tegmental area and substantia nigra pars compacta neurons. J. Neurophysiol. 96 5 (2006) 2295-2306
11. Gassen M., Glinka Y., et al. Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction. Eur. J. Pharmacol. 308 2 (1996) 219-225
12. Georgievska B., Kirik D., et al. Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp. Neurol. 177 2 (2002) 461-474
13. Glinka Y., Gassen M., et al. Mechanism of 6-hydroxydopamine neurotoxicity. J. Neural. Transm. Suppl. 50 (1997) 55-66
14. Glinka Y., Tipton K.F., et al. Mechanism of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine and its prevention by desferrioxamine. Eur. J. Pharmacol. 351 1 (1998) 121-129
15. Glinka Y.Y., and Youdim M.B. Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. Eur. J. Pharmacol. 292 3-4 (1995) 329-332
16. Gonzalez-Hernandez T., Barroso-Chinea P., et al. Colocalization of tyrosine hydroxylase and GAD65 mRNA in mesostriatal neurons. Eur. J. Neurosci. 13 1 (2001) 57-67
17. Grace A.A., and Onn S.P. Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro. J. Neurosci. 9 10 (1989) 3463-3481
18. Graham D.G. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14 4 (1978) 633-643
19. Graham D.G., Tiffany S.M., et al. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14 4 (1978) 644-653
20. Harris N.C., Webb C., et al. A possible pacemaker mechanism in pars compacta neurons of the guinea-pig substantia nigra revealed by various ion channel blocking agents. Neuroscience 31 2 (1989) 355-362
21. Horvitz J.C. Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience 96 4 (2000) 651-656
22. Ji H., and Shepard P.D. SK Ca2+-activated K+ channel ligands alter the firing pattern of dopamine-containing neurons in vivo. Neuroscience 140 2 (2006) 623-633
23. Keefe K.A., Sved A.F., et al. Stress-induced dopamine release in the neostriatum: evaluation of the role of action potentials in nigrostriatal dopamine neurons or local initiation by endogenous excitatory amino acids. J. Neurochem. 61 5 (1993) 1943-1952
24. Lacey M.G., Mercuri N.B., et al. Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids. J. Neurosci. 9 4 (1989) 1233-1241
25. Lee C.S., Sauer H., et al. Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat. Neuroscience 72 3 (1996) 641-653
26. Lie D.C., Dziewczapolski G., et al. The adult substantia nigra contains progenitor cells with neurogenic potential. J. Neurosci. 22 15 (2002) 6639-6649
27. Maker H.S., Weiss C., et al. Coupling of dopamine oxidation (monoamine oxidase activity) to glutathione oxidation via the generation of hydrogen peroxide in rat brain homogenates. J. Neurochem. 36 2 (1981) 589-593
28. Melamed E., Ziv I., et al. Management of motor complications in advanced Parkinson's disease. Mov. Disord. 22 Suppl 17 (2007) S379-S384
29. Nagamoto-Combs K., Piech K.M., et al. Tyrosine hydroxylase gene promoter activity is regulated by both cyclic AMP-responsive element and AP1 sites following calcium influx. Evidence for cyclic amp-responsive element binding protein-independent regulation. J. Biol. Chem. 272 9 (1997) 6051-6058
30. Nedergaard S., Flatman J.A., et al. Nifedipine- and omega-conotoxin-sensitive Ca2+ conductances in guinea-pig substantia nigra pars compacta neurones. J. Physiol. 466 (1993) 727-747
31. Nutt J.G., Woodward W.R., et al. Effect of long-term therapy on the pharmacodynamics of levodopa. Relation to on-off phenomenon. Arch. Neurol. 49 11 (1992) 1123-1130
32. Nutt J.G., Carter J.H., et al. Evolution of the response to levodopa during the first 4 years of therapy. Ann. Neurol. 51 6 (2002) 686-693
33. Parish C.L., Finkelstein D.I., et al. The role of dopamine receptors in regulating the size of axonal arbors. J. Neurosci. 21 14 (2001) 5147-5157
34. Rodriguez M., and Gonzalez-Hernandez T. Electrophysiological and morphological evidence for a GABAergic nigrostriatal pathway. J. Neurosci. 19 11 (1999) 4682-4694
35. Sabban E.L. Control of tyrosine hydroxylase gene expression in chromaffin and PC12 cells. Semin. Cell Dev. Biol. 8 2 (1997) 101-111
36. Sang T.K., Chang H.Y., et al. A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine. J. Neurosci. 27 5 (2007) 981-992
37. Sarpal D., Koenig J.I., et al. Regional distribution of SK3 mRNA-containing neurons in the adult and adolescent rat ventral midbrain and their relationship to dopamine-containing cells. Synapse 53 2 (2004) 104-113
38. Sauer H., and Oertel W.H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59 2 (1994) 401-415
39. Shepard P.D., and Bunney B.S. Repetitive firing properties of putative dopamine-containing neurons in vitro: regulation by an apamin-sensitive Ca(2+)-activated K+ conductance. Exp. Brain Res. 86 1 (1991) 141-150
40. Stanic D., Finkelstein D.I., et al. Timecourse of striatal re-innervation following lesions of dopaminergic SNpc neurons of the rat. Eur. J. Neurosci. 18 5 (2003) 1175-1188
41. Stokes A.H., Hastings T.G., et al. Cytotoxic and genotoxic potential of dopamine. J. Neurosci. Res. 55 6 (1999) 659-665
42. Sulzer D. alpha-synuclein and cytosolic dopamine: stabilizing a bad situation. Nat. Med. 7 12 (2001) 1280-1282
43. Tande D., Hoglinger G., et al. New striatal dopamine neurons in MPTP-treated macaques result from a phenotypic shift and not neurogenesis. Brain 129 Pt. 5 (2006) 1194-1200
44. Waroux O., Massotte L., et al. SK channels control the firing pattern of midbrain dopaminergic neurons in vivo. Eur. J. Neurosci. 22 12 (2005) 3111-3121
45. Wightman R.M., and Zimmerman J.B. Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake. Brain Res. Brain Res. Rev. 15 2 (1990) 135-144
46. Winkler C., Sauer H., et al. Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci. 16 22 (1996) 7206-7215
47. Wolfart J., Neuhoff H., et al. Differential expression of the small-conductance, calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons. J. Neurosci. 21 10 (2001) 3443-3456
48. Yung W.H., Hausser M.A., et al. Electrophysiology of dopaminergic and non-dopaminergic neurones of the guinea-pig substantia nigra pars compacta in vitro. J. Physiol. 436 (1991) 643-667
49. Zhang Y., Dawson V.L., et al. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol. Dis. 7 4 (2000) 240-250
50. Zhao M., Momma S., et al. Evidence for neurogenesis in the adult mammalian substantia nigra. Proc. Natl. Acad. Sci. U. S. A. 100 13 (2003) 7925-7930
51. Zigmond M.J., Castro S.L., et al. Role of excitatory amino acids in the regulation of dopamine synthesis and release in the neostriatum. Amino Acids 14 1-3 (1998) 57-62